P385 Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant inflammatory bowel disease patients
Bindia Jharap(Meander Medisch Centrum), Adriaan A. van Bodegraven(Maastricht University Medical Centre), Bram Wilhelm, Gerard Dijkstra(University Medical Center Groningen), C. Janneke van der Woude(Radboud University Nijmegen), Daniël W. Hommes(InterScience (United States)), R Van Elburg, D. de Jong, Nanne K.H. de Boer, Pieter Stokkers(Academic Medical Center), Bas Oldenburg(University Medical Center Utrecht)
Cited by 2
Related Papers
Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
|Clinical and Translational Gastroenterology|2016|724
Genome-wide association identifies multiple ulcerative colitis susceptibility loci
|Nature Genetics|2010|680
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
|Gastroenterology|2015|478